109 related articles for article (PubMed ID: 31078686)
21. Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments.
Petrelli F; Dallérac G; Pucci L; Calì C; Zehnder T; Sultan S; Lecca S; Chicca A; Ivanov A; Asensio CS; Gundersen V; Toni N; Knott GW; Magara F; Gertsch J; Kirchhoff F; Déglon N; Giros B; Edwards RH; Mothet JP; Bezzi P
Mol Psychiatry; 2020 Apr; 25(4):732-749. PubMed ID: 30127471
[TBL] [Abstract][Full Text] [Related]
22. Reduction of manganese intake improves neuropsychological manifestations in rats with minimal hepatic encephalopathy.
Li Y; Mei LH; Qiang JW; Ji CX; Ju S
Neuroscience; 2017 Apr; 347():148-155. PubMed ID: 28193543
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of Kir4.1 in the cerebral cortex of rats with liver failure and in cultured astrocytes treated with glutamine: Implications for astrocytic dysfunction in hepatic encephalopathy.
Obara-Michlewska M; Pannicke T; Karl A; Bringmann A; Reichenbach A; Szeliga M; Hilgier W; Wrzosek A; Szewczyk A; Albrecht J
J Neurosci Res; 2011 Dec; 89(12):2018-27. PubMed ID: 21538466
[TBL] [Abstract][Full Text] [Related]
24. Regulation of dopamine uptake by basic fibroblast growth factor and epidermal growth factor in cultured rat astrocytes.
Inazu M; Takeda H; Ikoshi H; Uchida Y; Kubota N; Kiuchi Y; Oguchi K; Matsumiya T
Neurosci Res; 1999 Sep; 34(4):235-44. PubMed ID: 10576546
[TBL] [Abstract][Full Text] [Related]
25. High glucose-induced defective thrombospondin-1 release from astrocytes via TLR9 activation contributes to the synaptic protein loss.
Zhao Y; Pu D; Sun Y; Chen J; Luo C; Wang M; Zhou J; Lv A; Zhu S; Liao Z; Zhao K; Xiao Q
Exp Cell Res; 2018 Feb; 363(2):171-178. PubMed ID: 29294308
[TBL] [Abstract][Full Text] [Related]
26. Dopamine alters AMPA receptor synaptic expression and subunit composition in dopamine neurons of the ventral tegmental area cultured with prefrontal cortex neurons.
Gao C; Wolf ME
J Neurosci; 2007 Dec; 27(52):14275-85. PubMed ID: 18160635
[TBL] [Abstract][Full Text] [Related]
27. What we know: the inflammatory basis of hepatic encephalopathy.
Milewski K; Oria M
Metab Brain Dis; 2016 Dec; 31(6):1239-1247. PubMed ID: 26497651
[TBL] [Abstract][Full Text] [Related]
28. Osmotic and oxidative/nitrosative stress in ammonia toxicity and hepatic encephalopathy.
Görg B; Schliess F; Häussinger D
Arch Biochem Biophys; 2013 Aug; 536(2):158-63. PubMed ID: 23567841
[TBL] [Abstract][Full Text] [Related]
29. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro.
Fasano C; Poirier A; DesGroseillers L; Trudeau LE
Eur J Neurosci; 2008 Oct; 28(8):1480-90. PubMed ID: 18973573
[TBL] [Abstract][Full Text] [Related]
30. Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells.
Reuss B; Unsicker K
Mol Cell Neurosci; 2000 Dec; 16(6):781-92. PubMed ID: 11124897
[TBL] [Abstract][Full Text] [Related]
31. Oridonin prevents insulin resistance-mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy.
Wen F; Zhuge W; Wang J; Lu X; You R; Liu L; Zhuge Q; Ding S
J Cell Mol Med; 2020 Jan; 24(1):61-78. PubMed ID: 31568638
[TBL] [Abstract][Full Text] [Related]
32. [Dopamine inhibits glutamate-uptake ability of astrocytes via TAAR1-EAAT2 pathway].
Wen F; Liu L; Xu Z; Yang J; Ding S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):930-935. PubMed ID: 28712400
[TBL] [Abstract][Full Text] [Related]
33. Increased proliferation and gliogenesis of cultured rat neural progenitor cells by lipopolysaccharide-stimulated astrocytes.
Go HS; Shin CY; Lee SH; Jeon SJ; Kim KC; Choi CS; Ko KH
Neuroimmunomodulation; 2009; 16(6):365-76. PubMed ID: 19609085
[TBL] [Abstract][Full Text] [Related]
34. Apomorphine-induced activation of dopamine receptors modulates FGF-2 expression in astrocytic cultures and promotes survival of dopaminergic neurons.
Li A; Guo H; Luo X; Sheng J; Yang S; Yin Y; Zhou J; Zhou J
FASEB J; 2006 Jun; 20(8):1263-5. PubMed ID: 16636101
[TBL] [Abstract][Full Text] [Related]
35. Oral magnesium sulphate administration in rats with minimal hepatic encephalopathy: NMR-based metabolic characterization of the brain.
Liu XF; Lu JJ; Li Y; Yang XY; Qiang JW
Magnes Res; 2022 Apr; 35(2):39-50. PubMed ID: 36354241
[TBL] [Abstract][Full Text] [Related]
36. Cerebral oxygen consumption in experimental hepatic encephalopathy: different responses in astrocytes, neurons, and synaptosomes.
Albrecht J; Wysmyk-Cybula U; Rafałowska U
Exp Neurol; 1987 Aug; 97(2):418-22. PubMed ID: 3609222
[TBL] [Abstract][Full Text] [Related]
37. Cocaine and HIV-1 Tat disrupt cholesterol homeostasis in astrocytes: Implications for HIV-associated neurocognitive disorders in cocaine user patients.
Cotto B; Natarajaseenivasan K; Ferrero K; Wesley L; Sayre M; Langford D
Glia; 2018 Apr; 66(4):889-902. PubMed ID: 29330881
[TBL] [Abstract][Full Text] [Related]
38. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy.
Görg B; Karababa A; Shafigullina A; Bidmon HJ; Häussinger D
Glia; 2015 Jan; 63(1):37-50. PubMed ID: 25092802
[TBL] [Abstract][Full Text] [Related]
39. The role of astrocytes in hepatic encephalopathy.
Norenberg MD
Neurochem Pathol; 1987; 6(1-2):13-33. PubMed ID: 3306480
[TBL] [Abstract][Full Text] [Related]
40. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
